Sincrolab — Seed (estimated) · €1.7M

Sincrolab raised €1.7M in a round led by Clave Capital through its healthcare fund Clave Innohealth, with Growth Venture Partners, Eoniq Fund and previous investors also taking part. The company develops AI-based digital therapies for cognitive disorders, focused on ADHD in children aged 7-15, and will use the capital for Spanish and European expansion and new products slated for 2025; it was Clave Innohealth's eighth investment since 2022.